Effects of alcohol, cigarettes, methamphetamine and marijuana exposure during pregnancy on maternal serum alpha-fetoprotein levels at 20-24 weeks'gestation
- PMID: 31106259
- PMCID: PMC6519948
Effects of alcohol, cigarettes, methamphetamine and marijuana exposure during pregnancy on maternal serum alpha-fetoprotein levels at 20-24 weeks'gestation
Abstract
Objective: To examine the effects of cigarette, marihuana and methamphetamine smoking and consumption of alcohol during pregnancy on maternal serum alpha-fetoprotein (MSAFP) levels at 20-24 weeks.
Study design: In the Safe Passage Study (SPS) more than 12,000 pregnant women were prospectively followed up during pregnancy and until the infant was one year old to examine the effects of exposure to alcohol during pregnancy on stillbirth and sudden infant death syndrome. The present study is a cross-sectional secondary analysis of MSAFP analyses done at 20-24 weeks gestation in 1,679 SPS participants, recruited at the Bishop Lavis Community Health Centre, Cape Town, South Arica.
Results: Low or moderate alcohol consumption with or without smoking, nor methamphetamine or marihuana use affected mean MSAFP levels. High MSAFP levels were associated with high alcohol consumption, young age, low body mass index (BMI) (<18 kg/m2) or small mid upper arm circumference (MUAC) (<230mm). High MSAFP levels were associated with stillbirth, preterm birth, abruption and a birth weight z-score of less than -1.
Conclusion: The study confirms the association between high MSAFP levels and adverse pregnancy outcomes but, although exposure to smoking or drinking is associated with adverse pregnancy outcomes including stillbirth, MSAFP levels were not affected by any of these exposures except for continued high consumption of alcohol. The observed association between higher MSAFP levels and maternal nutritional status (as demonstrated by the lower MUAC and BMI) could explain some of the correlations of poor socioeconomic conditions with higher stillbirth rates effect.
Keywords: Z scores; alcohol; alpha-fetoprotein; birth weight; placental abruption; pregnancy; preterm birth; stillbirth; tobacco.
Conflict of interest statement
Conflict of interest The authors have no conflict to declare.
Figures





Similar articles
-
Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome(1).Obstet Gynecol. 2001 Feb;97(2):277-82. doi: 10.1016/s0029-7844(00)01109-1. Obstet Gynecol. 2001. PMID: 11165595
-
Maternal serum alpha fetoprotein among pregnant females in Alexandria.J Egypt Public Health Assoc. 2004;79(1-2):59-81. J Egypt Public Health Assoc. 2004. PMID: 16916050
-
The association between second-trimester maternal serum alpha-fetoprotein in 14-22 weeks and adverse pregnancy outcome.Acta Med Iran. 2010 Jul-Aug;48(4):234-8. Acta Med Iran. 2010. PMID: 21279936
-
Unexplained elevations of maternal serum alpha-fetoprotein.Obstet Gynecol Surv. 1990 Nov;45(11):719-26. doi: 10.1097/00006254-199011000-00001. Obstet Gynecol Surv. 1990. PMID: 1700347 Review.
-
Risk of stillbirth, preterm delivery, and fetal growth restriction following exposure in a previous birth: systematic review and meta-analysis.BJOG. 2018 Jan;125(2):183-192. doi: 10.1111/1471-0528.14906. Epub 2017 Oct 3. BJOG. 2018. PMID: 28856792
Cited by
-
The tragedy of smoking, alcohol, and multiple substance use during pregnancy.S Afr Med J. 2022 Aug 2;112(8):526-538. doi: 10.7196/SAMJ.2022.v112i8.16480. S Afr Med J. 2022. PMID: 36214396 Free PMC article.
-
Smoking and drinking habits of women in subsequent pregnancies after specific advice about the dangers of these exposures during pregnancy.S Afr Med J. 2020 Oct 28;110(11):1100-1104. doi: 10.7196/SAMJ.2020.v110i11.14667. S Afr Med J. 2020. PMID: 33403986 Free PMC article.
-
Substance and alcohol use in pregnant women attending antenatal care at a tertiary hospital in Johannesburg, South Africa.S Afr J Psychiatr. 2025 May 14;31:2444. doi: 10.4102/sajpsychiatry.v31i0.2444. eCollection 2025. S Afr J Psychiatr. 2025. PMID: 40469806 Free PMC article.
References
-
- Frøen JF, Cacciatore J, McClure EM, et al. Stillbirths: Why they matter. Lancet 2011;377(9774): 1353–1366. - PubMed
-
- Brock D, Scrimgeour J, Steven J, et al. Maternal plasma alpha-fetoprotein screening for fetal neural tube defects. BJOG: Int J Obstet Gynaecol 1978;85(8):575–581. - PubMed
-
- Smith GCS, Shah I, White IR, et al. Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death. BJOG Int J Obstet Gynaecol. 2007; 114(6):705–714. - PubMed
-
- Bartha JL, Illanes S, González-Bugatto F, et al. Maternal serum transformed a-fetoprotein levels in women with intrauterine growth retardation. Fetal Diagn Ther. 2007;22(4):294–298. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources